Pfizer sees high demand for COVID-19 pill as profits jump

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 33 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 66%

Singapore Headlines News

Singapore Latest News,Singapore Headlines

NEW YORK: Pfizer executives said Tuesday (May 3) they are confident of strong demand for the company\u0027s COVID-19 antiviral treatment amid easing pandemic rules as the big drugmaker reported another round of strong earnings. The US pharmaceutical giant, reporting surging first-quarter profits based on a big

NEW YORK: Pfizer executives said Tuesday they are confident of strong demand for the company's COVID-19 antiviral treatment amid easing pandemic rules as the big drugmaker reported another round of strong earnings.

Citing rising vaccine fatigue, Bourla said the company is also focused on a Covid-19 vaccine booster that provides immunity for a year. Pfizer lowered its full-year adjusted profits by 10 cents to US$6.25 to US$6.45 a share, due in part to currency movements. In the first quarter, Paxlovid took in US$1.5 billion in global sales. But Pfizer expects 2022 sales of the medicine of US$22 billion as it ramps up production and distribution.

"What we are seeing is ... there is demand for this product," said Pfizer biopharmaceuticals group president Angela Hwang, citing the removal of mask mandates as a factor in spreading cases.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in SG

Singapore Latest News, Singapore Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Pfizer keeps COVID-19 sales forecast unchanged as pandemic curbs easePfizer maintained sales forecasts for its COVID-19 products on Tuesday (May 3) after a series of hikes to the sales outlook for its COVID-19 vaccine last year, in a sign that dizzying growth has slowed. Several countries across the globe have eased pandemic-linked restrictions and relaxed rules related to Being cancer-stricken and begging CPF Board to repay overdue debt; that which in any case cannot be done as the money had been commingled and funneled to private entity Temasek Holdings for Ho Ching to wager on unviable, untenable and ultimately, invariably doomed gambles
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

1,508 new local Covid-19 cases in S'pore, continuing decline since Feb
Source: straits_times - 🏆 5. / 69 Read more »

1,508 new local Covid-19 cases in S'pore, continuing decline since FebDaily Covid-19 cases in Singapore continued to decline, with 1,508 local cases reported on Tuesday (May 3), said the Ministry of Health (MOH) in an update on its website. This was lower than the 3,633 local cases reported last Tuesday (April 26) and the 4,544 on April...
Source: thenewpaper - 🏆 7. / 63 Read more »

Fitch cuts China's 2022 GDP forecast to 4.3% from 4.8% on COVID-19 hitFitch said on Tuesday (May 3) it has cut China\u0027s GDP growth forecast for 2022 to 4.3 per cent from 4.8 per cent, saying pandemic-related disruptions have had an impact on the country\u0027s economy in the first two quarters of the year. The rating agency said it stills expects a quarter-over-quarter GDP co
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Hong Kong Q1 GDP shrinks more than expected on COVID-19 curbsHONG KONG: Hong Kong\u0027s economy contracted in the first quarter of this year as the city imposed its most stringent restrictions to curb an outbreak of COVID-19 that has battered business, led to an exodus of people and overshadowed the outlook for growth. The financial centre\u0027s economy shrank 4 per cent\u0026nb
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Business travel on the rise again with eased Covid-19 border restrictions worldwide
Source: straits_times - 🏆 5. / 69 Read more »